Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cangene to evaluate Leucotropin in phase III

Dec. 15, 1997

Discovery of novel, orally active ACAT inhibitor, FR-186054, reported by Fujisawa

Dec. 15, 1997

Novel hypoglycemic thiazolidinedione derivative presented by Kyorin

Dec. 15, 1997

TheraTech and P&G to codevelop hormone replacement patches

Dec. 12, 1997

Site-directed, sustained-release delivery system for estradiol in development at Fujisawa

Dec. 12, 1997

Kyowa Hakko prepares new, water-soluble indole for osteoporosis

Dec. 12, 1997

Tokyo Tanabe moves new oxytocin antagonist to clinic

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Potential new male contraceptive under development in China

Dec. 11, 1997

Sparta acquires rights to PZG

Dec. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...